{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:00:53Z","timestamp":1790186453990,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Yongchuan District, Chongqing City","award":["Ycstc,2020nb0252"],"award-info":[{"award-number":["Ycstc,2020nb0252"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02253-w","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T06:25:14Z","timestamp":1784442314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuropeptide Y promotes myocardial fibrosis post myocardial infarction reperfusion through Neuropeptide Y receptor type 1"],"prefix":"10.1007","volume":"26","author":[{"given":"Dinghui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,19]]},"reference":[{"key":"2253_CR1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","volume":"43","author":"A Timmis","year":"2022","unstructured":"Timmis A, et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43:716\u201399. https:\/\/doi.org\/10.1093\/eurheartj\/ehab892.","journal-title":"Eur Heart J"},{"key":"2253_CR2","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"regional Global","year":"2018","unstructured":"Global regional. national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736\u201388. https:\/\/doi.org\/10.1016\/S0140-6736(18)32203-7.","journal-title":"Lancet"},{"key":"2253_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3967\/bes2023.106","volume":"36","author":"WCOTROCH The","year":"2023","unstructured":"The WCOTROCH. Diseases In, C. Report on Cardiovascular Health and Diseases in China 2022: an Updated Summary. Biomed Environ Sci. 2023;36:669\u2013701. https:\/\/doi.org\/10.3967\/bes2023.106.","journal-title":"Biomed Environ Sci"},{"key":"2253_CR4","doi-asserted-by":"publisher","first-page":"5485","DOI":"10.1073\/pnas.79.18.5485","volume":"79","author":"K Tatemoto","year":"1982","unstructured":"Tatemoto K, Neuropeptide Y. complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA. 1982;79:5485\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2253_CR5","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3389\/fphys.2018.01281","volume":"9","author":"CMJ Tan","year":"2018","unstructured":"Tan CMJ, et al. The Role of Neuropeptide Y in Cardiovascular Health and Disease. Front Physiol. 2018;9:1281. https:\/\/doi.org\/10.3389\/fphys.2018.01281.","journal-title":"Front Physiol"},{"key":"2253_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3389\/fnins.2019.00869","volume":"13","author":"C Li","year":"2019","unstructured":"Li C, et al. Roles of Neuropeptide Y in Neurodegenerative and Neuroimmune Diseases. Front Neurosci. 2019;13:869. https:\/\/doi.org\/10.3389\/fnins.2019.00869.","journal-title":"Front Neurosci"},{"key":"2253_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3991","author":"X Kang","year":"2020","unstructured":"Kang X, et al. Neuropeptide Y Acts Directly on Cartilage Homeostasis and Exacerbates Progression of Osteoarthritis Through NPY2R. J Bone Min Res. 2020. https:\/\/doi.org\/10.1002\/jbmr.3991.","journal-title":"J Bone Min Res"},{"key":"2253_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.molmet.2019.11.009","volume":"31","author":"S Wittrisch","year":"2020","unstructured":"Wittrisch S, et al. NPYR-targeted peptide-mediated delivery of a dual PPAR\u03b1\/\u03b3 agonist to adipocytes enhances adipogenesis and prevents diabetes progression. Mol Metab. 2020;31:163\u201380. https:\/\/doi.org\/10.1016\/j.molmet.2019.11.009.","journal-title":"Mol Metab"},{"key":"2253_CR9","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41569-019-0178-1","volume":"16","author":"L Calvillo","year":"2019","unstructured":"Calvillo L, Gironacci MM, Crotti L, Meroni PL, Parati G. Neuroimmune crosstalk in the pathophysiology of hypertension. Nat Rev Cardiol. 2019;16:476\u201390. https:\/\/doi.org\/10.1038\/s41569-019-0178-1.","journal-title":"Nat Rev Cardiol"},{"key":"2253_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10571-011-9793-z","volume":"32","author":"D Hirsch","year":"2012","unstructured":"Hirsch D, Zukowska Z. NPY and stress 30 years later: the peripheral view. Cell Mol Neurobiol. 2012;32:645\u201359. https:\/\/doi.org\/10.1007\/s10571-011-9793-z.","journal-title":"Cell Mol Neurobiol"},{"key":"2253_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s13770-018-0134-x","volume":"15","author":"J Lee","year":"2018","unstructured":"Lee J, Song M, Kim J, Park Y. Comparison of Angiogenic Activities of Three Neuropeptides, Substance P, Secretoneurin, and Neuropeptide Y Using Myocardial Infarction. Tissue Eng Regen Med. 2018;15:493\u2013502. https:\/\/doi.org\/10.1007\/s13770-018-0134-x.","journal-title":"Tissue Eng Regen Med"},{"key":"2253_CR12","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1136\/heartjnl-2012-303443","volume":"99","author":"F Cuculi","year":"2013","unstructured":"Cuculi F, et al. Relationship of plasma neuropeptide Y with angiographic, electrocardiographic and coronary physiology indices of reperfusion during ST elevation myocardial infarction. Heart. 2013;99:1198\u2013203. https:\/\/doi.org\/10.1136\/heartjnl-2012-303443.","journal-title":"Heart"},{"key":"2253_CR13","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1093\/eurheartj\/ehz115","volume":"40","author":"N Herring","year":"2019","unstructured":"Herring N, et al. Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction. Eur Heart J. 2019;40:1920\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehz115.","journal-title":"Eur Heart J"},{"key":"2253_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.4717","author":"OA Ajijola","year":"2019","unstructured":"Ajijola OA, et al. Coronary Sinus Neuropeptide Y Levels and Adverse Outcomes in Patients With Stable Chronic Heart Failure. JAMA Cardiol. 2019. https:\/\/doi.org\/10.1001\/jamacardio.2019.4717.","journal-title":"JAMA Cardiol"},{"key":"2253_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz852","author":"M Kalla","year":"2019","unstructured":"Kalla M, et al. The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade. Eur Heart J. 2019. https:\/\/doi.org\/10.1093\/eurheartj\/ehz852.","journal-title":"Eur Heart J"},{"key":"2253_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/5584_2019_427","volume":"1237","author":"P Shende","year":"2020","unstructured":"Shende P, Desai D. Physiological and Therapeutic Roles of Neuropeptide Y on Biological Functions. Adv Exp Med Biol. 2020;1237:37\u201347. https:\/\/doi.org\/10.1007\/5584_2019_427.","journal-title":"Adv Exp Med Biol"},{"key":"2253_CR17","doi-asserted-by":"publisher","first-page":"e17993","DOI":"10.1111\/jcmm.17993","volume":"28","author":"NH Ali","year":"2024","unstructured":"Ali NH, et al. Neprilysin inhibitors and risk of Alzheimer\u2019s disease: A future perspective. J Cell Mol Med. 2024;28:e17993. https:\/\/doi.org\/10.1111\/jcmm.17993.","journal-title":"J Cell Mol Med"},{"key":"2253_CR18","doi-asserted-by":"publisher","unstructured":"Assan D, et al. The Roles of Neuropeptide Y (Npy) and Peptide YY (Pyy) in Teleost Food Intake: A Mini Review. Life (Basel Switzerland). 2021;11. https:\/\/doi.org\/10.3390\/life11060547.","DOI":"10.3390\/life11060547"},{"key":"2253_CR19","doi-asserted-by":"publisher","first-page":"833485","DOI":"10.3389\/fendo.2022.833485","volume":"13","author":"Q-C Chen","year":"2022","unstructured":"Chen Q-C, Zhang Y. The Role of NPY in the Regulation of Bone Metabolism. Front Endocrinol. 2022;13:833485. https:\/\/doi.org\/10.3389\/fendo.2022.833485.","journal-title":"Front Endocrinol"},{"key":"2253_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/jnc.15125","volume":"156","author":"CM Clark","year":"2021","unstructured":"Clark CM, Clark RM, Hoyle JA, Dickson TC. Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis. J Neurochem. 2021;156:273\u201389. https:\/\/doi.org\/10.1111\/jnc.15125.","journal-title":"J Neurochem"},{"key":"2253_CR21","doi-asserted-by":"publisher","first-page":"110349","DOI":"10.1016\/j.pnpbp.2021.110349","volume":"111","author":"H Domin","year":"2021","unstructured":"Domin H, Neuropeptide. Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies. Prog Neuropsychopharmacol Biol Psychiatry. 2021;111:110349. https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110349.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2253_CR22","doi-asserted-by":"publisher","first-page":"102896","DOI":"10.1016\/j.arcmed.2023.102896","volume":"54","author":"A Ferreira-Hermosillo","year":"2023","unstructured":"Ferreira-Hermosillo A, de Miguel Iba\u00f1ez R, P\u00e9rez-Dionisio EK. Villalobos-Mata, K. A. Obesity as a Neuroendocrine Disorder. Arch Med Res. 2023;54:102896. https:\/\/doi.org\/10.1016\/j.arcmed.2023.102896.","journal-title":"Arch Med Res"},{"key":"2253_CR23","doi-asserted-by":"publisher","first-page":"695623","DOI":"10.3389\/fcell.2021.695623","volume":"9","author":"Y Huang","year":"2021","unstructured":"Huang Y, Lin X, Lin S, Neuropeptide Y. Metabolism Syndrome: An Update on Perspectives of Clinical Therapeutic Intervention Strategies. Front Cell Dev Biol. 2021;9:695623. https:\/\/doi.org\/10.3389\/fcell.2021.695623.","journal-title":"Front Cell Dev Biol"},{"key":"2253_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jaci.2023.05.004","volume":"152","author":"L Misery","year":"2023","unstructured":"Misery L, et al. Basic mechanisms of itch. J Allergy Clin Immunol. 2023;152:11\u201323. https:\/\/doi.org\/10.1016\/j.jaci.2023.05.004.","journal-title":"J Allergy Clin Immunol"},{"key":"2253_CR25","doi-asserted-by":"publisher","first-page":"110478","DOI":"10.1016\/j.pnpbp.2021.110478","volume":"114","author":"T Rana","year":"2022","unstructured":"Rana T, et al. Exploring the role of neuropeptides in depression and anxiety. Prog Neuropsychopharmacol Biol Psychiatry. 2022;114:110478. https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110478.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2253_CR26","doi-asserted-by":"publisher","unstructured":"Reichmann F, Holzer P, Neuropeptide Y. A stressful review. Neuropeptides. 2016;55. https:\/\/doi.org\/10.1016\/j.npep.2015.09.008.","DOI":"10.1016\/j.npep.2015.09.008"},{"key":"2253_CR27","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez ML, Rodr\u00edguez FD, Cove\u00f1as R, Neuropeptide. Y Peptide Family and Cancer: Antitumor Therapeutic Strategies. Int J Mol Sci. 2023;24. https:\/\/doi.org\/10.3390\/ijms24129962.","DOI":"10.3390\/ijms24129962"},{"key":"2253_CR28","doi-asserted-by":"publisher","DOI":"10.1159\/000533405","author":"P Wang","year":"2023","unstructured":"Wang P, et al. Circulating neuropeptide Y may be a biomarker for diagnosing atrial fibrillation. Cardiology. 2023. https:\/\/doi.org\/10.1159\/000533405.","journal-title":"Cardiology"},{"key":"2253_CR29","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3389\/fimmu.2019.01701","volume":"10","author":"B Choi","year":"2019","unstructured":"Choi B, et al. Elevated Neuropeptide Y in Endothelial Dysfunction Promotes Macrophage Infiltration and Smooth Muscle Foam Cell Formation. Front Immunol. 2019;10:1701. https:\/\/doi.org\/10.3389\/fimmu.2019.01701.","journal-title":"Front Immunol"},{"key":"2253_CR30","doi-asserted-by":"publisher","first-page":"e024850","DOI":"10.1161\/JAHA.121.024850","volume":"11","author":"T Gibbs","year":"2022","unstructured":"Gibbs T, et al. Neuropeptide-Y Levels in ST-Segment-Elevation Myocardial Infarction: Relationship With Coronary Microvascular Function, Heart Failure, and Mortality. J Am Heart Assoc. 2022;11:e024850. https:\/\/doi.org\/10.1161\/JAHA.121.024850.","journal-title":"J Am Heart Assoc"},{"key":"2253_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2016.02.033","volume":"776","author":"R Saraf","year":"2016","unstructured":"Saraf R, Mahmood F, Amir R, Matyal R. Neuropeptide Y is an angiogenic factor in cardiovascular regeneration. Eur J Pharmacol. 2016;776:64\u201370. https:\/\/doi.org\/10.1016\/j.ejphar.2016.02.033.","journal-title":"Eur J Pharmacol"},{"key":"2253_CR32","doi-asserted-by":"publisher","first-page":"113674","DOI":"10.1016\/j.celrep.2024.113674","volume":"43","author":"R Kumari","year":"2024","unstructured":"Kumari R, et al. Sympathetic NPY controls glucose homeostasis, cold tolerance, and cardiovascular functions in mice. Cell Rep. 2024;43:113674. https:\/\/doi.org\/10.1016\/j.celrep.2024.113674.","journal-title":"Cell Rep"},{"key":"2253_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.npep.2018.11.009","volume":"73","author":"NK Wee","year":"2019","unstructured":"Wee NK. Skeletal phenotype of the neuropeptide Y knockout mouse. Neuropeptides. 2019;73:78\u201388. https:\/\/doi.org\/10.1016\/j.npep.2018.11.009.","journal-title":"Neuropeptides"},{"key":"2253_CR34","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.1073\/pnas.1135965100","volume":"100","author":"AJ Ekstrand","year":"2003","unstructured":"Ekstrand AJ, et al. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci U S A. 2003;100:6033\u20138. https:\/\/doi.org\/10.1073\/pnas.1135965100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2253_CR35","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3389\/fphar.2019.01268","volume":"10","author":"W Huang","year":"2019","unstructured":"Huang W, et al. Deletion of Neuropeptide Y Attenuates Cardiac Dysfunction and Apoptosis During Acute Myocardial Infarction. Front Pharmacol. 2019;10:1268. https:\/\/doi.org\/10.3389\/fphar.2019.01268.","journal-title":"Front Pharmacol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02253-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02253-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02253-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:02:50Z","timestamp":1790182970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02253-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2253"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02253-w","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,19]]},"assertion":[{"value":"23 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the ethical principles of the Declaration of Helsinki, and the protocol was approved by the institutional review board of Ethics Committee of Yongchuan Hospital Affiliated to Chongqing Medical University, Review No. 020 of 2023.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This animal study protocol was approved by the Chongqing medical University. And the study is reported in accordance with ARRIVE guidelines (\n                      \n                      ).","order":3,"name":"Ethics","label":"Institutional Review Board Statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"338"}}